Benzinga

Benzinga

Benzinga

miércoles, agosto 19

Edesa Biotech Inc

EDSANASDAQ
Trade with Public
Trade with Public
$5.71
0.061.06%
al cierre: Aug 18, 5:00 PM EST
$6.09
0.386.59%
After hour: 7:40 PM EST
Ganancias: Los beneficios de Q3 2026 se publicaron el jue ago 13th, después del cierre del mercado
Panorámica generalNoticiasPrevisión de beneficiosEventosPrecios objetivoFinanzasSentimientoPropiedadCompararInforme de acciones

Edesa Biotech Analyst Price Targets

Wall Street analyst price targets and consensus rating for Edesa Biotech (EDSA).

Price Target Range — 7 Quarters

Analyst Consensus — 2 Analysts

2Buy
Consensus RatingBuy# Analysts2Avg. Consensus PT$28Upside to Avg. PT+354.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Nov 3, 2025HC Wainwright & Co.Yi ChenMaintainedBuy$5
Jun 27, 2025HC Wainwright & Co.Yi ChenAssumesBuy$5
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Edesa Biotech, Maintains $5 Price Target

HC Wainwright & Co. analyst Yi Chen reiterates Edesa Biotech (NASDAQ:EDSA) with a Buy and maintains $5 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Assumes Edesa Biotech at Buy, Announces Price Target of $5

HC Wainwright & Co. analyst Yi Chen assumes Edesa Biotech (NASDAQ:EDSA) with a Buy rating and announces Price Target of $5.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Edesa Biotech, Maintains $21 Price Target

HC Wainwright & Co. analyst Vernon Bernardino reiterates Edesa Biotech (NASDAQ:EDSA) with a Buy and maintains $21 price target.
Benzinga Newsdesk

PRO
Watching Edesa Biotech; Zacks Small-Cap Research Gives Stock $17 Price Valuation

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Edesa Biotech, Maintains $21 Price Target

HC Wainwright & Co. analyst Vernon Bernardino reiterates Edesa Biotech (NASDAQ:EDSA) with a Buy and maintains $21 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Edesa Biotech, Maintains $21 Price Target

HC Wainwright & Co. analyst Vernon Bernardino reiterates Edesa Biotech (NASDAQ:EDSA) with a Buy and maintains $21 price target.
Benzinga Newsdesk

Datos y APIs: APIs de Benzinga · API de noticias de acciones · API de calificaciones de analistas · API de logotipos de empresas

Datos de mercado proporcionados por APIs de Benzinga

Benzinga

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

© 2026 Benzinga | All Rights Reserved